---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-033059"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2023-09-19T23:59:59+00:00"
generated_at: "2026-06-10T13:30:52.896133+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics amends convertible notes: extends maturity to Aug 2024, increases principal

## Summary
- Entered amendment agreements for $2,161,316 of convertible notes, extending maturity to August 30, 2024.
- Principal increased to reflect implied 12% interest rate from amendment date through new maturity.
- Upon national exchange listing, notes automatically convert into Series A Convertible Preferred Stock.
- Company expects to enter similar amendments with remaining holders of $3,051,516 principal notes (as of June 30, 2023).

## SEC filing metadata
- accession: 0001493152-23-033059
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2023-09-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/0001493152-23-033059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-033059
- JSON: https://secwatch.observer/filing/0001493152-23-033059.json
- Plain text: https://secwatch.observer/filing/0001493152-23-033059.txt

## Key facts
- Material Agreements
  Sigyn Therapeutics, Inc. amended Amendment Agreement with certain accredited investors valued at $2,161,316 principal amount (effective 2023-09-14).
  - Action: amendment
  - Counterparty: certain accredited investors
  - Value: $2,161,316 principal amount
  - Effective: 2023-09-14
  source text: On September 14, 2023, the Company entered into Amendment Agreements with $2,161,316 principal amount of these notes to extend the maturity date to August 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642159/000149315223033059/0001493152-23-033059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.